N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) Peptide
NAT2
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN937133
Aperçu rapide pour N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) Peptide (ABIN937133)
Antigène
NAT2
(N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- CLTEERGIWY LDQIRREQYI TNKEFLNSHL LPKKKHQKIY LFTLEPRTIE
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NAT2 antibody,
Alternative Names: NAT2 control peptide, NAT2 antibody Blocking Peptide, Anti-NAT2 Blocking Peptide, N-Acetyltransferase 2 Blocking Peptide, Arylamine N-Acetyltransferase Blocking Peptide, AAC2 Blocking Peptide, NAT2, NAT-2, NAT 2, NAT-2 Blocking Peptide, NAT 2 Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- NAT2 (N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2))
-
Sujet
- NAT2 is a N-acetyltransferase 2 (arylamine N-acetyltransferase 2). This enzyme functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in its gene are reponsible for the N-acetylation polymorphism in which human populations segregate into rapid,intermediate, and slow acetylator phenotypes. Polymorphisms in NAT2 are also associated with higher incidences of cancer and drug toxicity.
-
Poids moléculaire
- 32 kDa
Antigène
-
Vous êtes ici:
